MiR-153-5p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Paclitaxel by Inducing G2M Phase Arrest
Yang Wang et al, 2020, OncoTargets and Therapy CrossRef
Carrier-Free Nanoparticles via Coassembly of Paclitaxel and Gambogic Acid with Folate-Functionalized Albumin for Targeted Tumor Treatment Fanchao Meng et al, 2024, ACS Applied Nano Materials CrossRef
Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer Wenjie Zhao et al, 2021, Frontiers in Pharmacology CrossRef
Targeted Chinese Medicine Delivery by A New Family of Biodegradable Pseudo-Protein Nanoparticles for Treating Triple-Negative Breast Cancer: In Vitro and In Vivo Study Hiu Yee Kwan et al, 2021, Frontiers in Oncology CrossRef
Therapeutic effect and metabolic fingerprinting of triple-negative breast cancer cells following exposure to a novel pH-responsive, gambogic acid-loaded micelle Mengting Da et al, 2024, Nanotechnology CrossRef
Unveiling the Potency of Phyto-Constituents to Target TNBC: Mechanism to Therapeutics Sreekumar Usha Devi Aiswarya et al, 2023, Therapeutic Drug Targets and Phytomedicine For Triple Negative Breast Cancer CrossRef
Resistance to Intervention: Paclitaxel in Breast Cancer Vipin Mohan Dan et al, 2021, Mini-Reviews in Medicinal Chemistry CrossRef
MiR-1275 Targeting SPARC Promotes Gambogic Acid-Induced Inhibition of Gastric Cancer Ang Cai et al, 2023, Biochemical Genetics CrossRef
Herbal Medicine: Prejudice to Realm of Reality Against TNBC Balachandran S. Vinod et al, 2023, Therapeutic Drug Targets and Phytomedicine For Triple Negative Breast Cancer CrossRef
Gambogic Acid Lysinate-induced Cervical Cancer SiHa Cells Apoptosis in vitro and in vivo Jie Niu et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef